BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21457075)

  • 1. Mechanism of gene transfection by polyamidoamine (PAMAM) dendrimers modified with ornithine residues.
    Kumar A; Yellepeddi VK; Vangara KK; Strychar KB; Palakurthi S
    J Drug Target; 2011 Nov; 19(9):770-80. PubMed ID: 21457075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced gene transfection efficiency by polyamidoamine (PAMAM) dendrimers modified with ornithine residues.
    Kumar A; Yellepeddi VK; Davies GE; Strychar KB; Palakurthi S
    Int J Pharm; 2010 Jun; 392(1-2):294-303. PubMed ID: 20363307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotinylated poly(amido)amine (PAMAM) dendrimers as carriers for drug delivery to ovarian cancer cells in vitro.
    Yellepeddi VK; Kumar A; Palakurthi S
    Anticancer Res; 2009 Aug; 29(8):2933-43. PubMed ID: 19661298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the nanostructure of dendrimer/DNA complexes on their endocytosis and gene expression.
    Peng SF; Su CJ; Wei MC; Chen CY; Liao ZX; Lee PW; Chen HL; Sung HW
    Biomaterials; 2010 Jul; 31(21):5660-70. PubMed ID: 20399497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport of surface engineered polyamidoamine (PAMAM) dendrimers across IPEC-J2 cell monolayers.
    Pisal DS; Yellepeddi VK; Kumar A; Palakurthi S
    Drug Deliv; 2008 Nov; 15(8):515-22. PubMed ID: 18720134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfection efficiencies of PAMAM dendrimers correlate inversely with their hydrophobicity.
    Shakhbazau A; Isayenka I; Kartel N; Goncharova N; Seviaryn I; Kosmacheva S; Potapnev M; Shcharbin D; Bryszewska M
    Int J Pharm; 2010 Jan; 383(1-2):228-35. PubMed ID: 19770028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-toxic phototriggered gene transfection by PAMAM-porphyrin conjugates.
    Shieh MJ; Peng CL; Lou PJ; Chiu CH; Tsai TY; Hsu CY; Yeh CY; Lai PS
    J Control Release; 2008 Aug; 129(3):200-6. PubMed ID: 18541326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core.
    Zhang XQ; Wang XL; Huang SW; Zhuo RX; Liu ZL; Mao HQ; Leong KW
    Biomacromolecules; 2005; 6(1):341-50. PubMed ID: 15638538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of PAMAM dendrimer derivatives with enhanced buffering capacity and remarkable gene transfection efficiency.
    Yu GS; Bae YM; Choi H; Kong B; Choi IS; Choi JS
    Bioconjug Chem; 2011 Jun; 22(6):1046-55. PubMed ID: 21528924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to study dendriplexes II: Transfection and cytotoxicity.
    Shcharbin D; Pedziwiatr E; Blasiak J; Bryszewska M
    J Control Release; 2010 Jan; 141(2):110-27. PubMed ID: 19815039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short multi-armed polylysine-graft-polyamidoamine copolymer as efficient gene vectors.
    Pan S; Wang C; Zeng X; Wen Y; Wu H; Feng M
    Int J Pharm; 2011 Nov; 420(2):206-15. PubMed ID: 21893180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugation of polyamidoamine dendrimers on biodegradable microparticles for nonviral gene delivery.
    Zhang XQ; Intra J; Salem AK
    Bioconjug Chem; 2007; 18(6):2068-76. PubMed ID: 17848077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry.
    Albertazzi L; Gherardini L; Brondi M; Sulis Sato S; Bifone A; Pizzorusso T; Ratto GM; Bardi G
    Mol Pharm; 2013 Jan; 10(1):249-60. PubMed ID: 23163881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum tolerance and endosomal escape capacity of histidine-modified pDNA-loaded complexes based on polyamidoamine dendrimer derivatives.
    Wen Y; Guo Z; Du Z; Fang R; Wu H; Zeng X; Wang C; Feng M; Pan S
    Biomaterials; 2012 Nov; 33(32):8111-21. PubMed ID: 22898182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyamidoamine (PAMAM) dendrimers modified with short oligopeptides for early endosomal escape and enhanced gene delivery.
    Thuy le T; Mallick S; Choi JS
    Int J Pharm; 2015 Aug; 492(1-2):233-43. PubMed ID: 26187169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of polyamidoamine (PAMAM) succinamic acid dendrimers generation 4 with human serum albumin.
    Sekowski S; Buczkowski A; Palecz B; Gabryelak T
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Oct; 81(1):706-10. PubMed ID: 21788153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyamidoamine dendrimers with a modified Pentaerythritol core having high efficiency and low cytotoxicity as gene carriers.
    Wang Y; Kong W; Song Y; Duan Y; Wang L; Steinhoff G; Kong D; Yu Y
    Biomacromolecules; 2009 Mar; 10(3):617-22. PubMed ID: 19215068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone conjugation to polyamidoamine dendrimers G1 and G2 for enhanced transfection efficiency with an anti-inflammatory effect.
    Kim JY; Ryu JH; Hyun H; Kim HA; Choi JS; Yun Lee D; Rhim T; Park JH; Lee M
    J Drug Target; 2012 Sep; 20(8):667-77. PubMed ID: 22845839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers.
    Pisal DS; Yellepeddi VK; Kumar A; Kaushik RS; Hildreth MB; Guan X; Palakurthi S
    Int J Pharm; 2008 Feb; 350(1-2):113-21. PubMed ID: 17913410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on polyamidoamine dendrimers as efficient gene delivery vector.
    Hui Zhong ; He ZG; Zheng Li ; Li GY; Shen SR; Li XL
    J Biomater Appl; 2008 May; 22(6):527-44. PubMed ID: 17623709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.